On October 16, 2026, the Seoul High Court (Incheon Division) issued its decision on an appeal in a preliminary injunction proceeding brought by a biopharmaceutical manufacturer (the “Company”) against its labor union to enjoin industrial action. The High Court held that all nine (9) processes in the Company’s manufacturing operations, from cell culture through purification, constitute work that must be maintained under Article 38(2) of the Trade Union and Labor Relations Adjustment Act (the “Trade Union Act”) (the “Decision”). These processes must therefore continue at normal operating levels even during industrial action. Kim & Chang represented the Company at both the lower court and High Court and secured this outcome.
|
1. |
Background |
|
(1) |
The Statutory Framework |
|
(2) |
The Dispute |
|
2. |
Key Holdings for the Decision |
|
3. |
Significance of the Decision |
|
(1) |
Work That Is Productive in Nature May Qualify as Preservation Work |
|
(2) |
“Normal” Performance is Measured Against Pre-Strike Operations |
|
(3) |
A Preventive Remedy in a Changed Legal Landscape |
|
4. |
Practical Considerations |
Related Topics
#Strike #Preservation Work #Labor Union #Preliminary Injunction




